Asian Spectator

Men's Weekly

.

SINOMED(R) Completes One-Year Follow-Up of the PIONEER-III Eur...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TIANJIN, China, July 13, 2020 /PRNewswire-AsiaNet/-- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Diplomasi mendadak Prabowo jadi mediator AS - Iran: Langkah berani atau cari panggung?

(DPN)● Rencana Prabowo mediasi Amerika-Iran memicu keraguan.● Prabowo seakan ingin berperan seimbang untuk bertahan dari tekanan dari luar dan dalam negeri .● Tanpa daya tawar, media...

Masa depan padel: Antara gengsi atau turun kelas agar tren ini langgeng

● Padel sedang menjadi tren teratas aktivitas kaum urban sejak beberapa tahun terakhir.● Padel sudah menjelma sebagai validasi gaya hidup modern pemainnya.● Tren main padel akan sege...

The world’s largest climate finance deal was built to flounder: why funding fails to reach the front-line

Adopted in December 2015, the Paris Agreement commits countries to keeping global temperature rise below 2°C above pre-industrial levels. All 195 signatories set their own plans to meet this share...